Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Kearns

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
AMA Journal of Ethics|October 1, 2025
Is the UDN N-of-1 Enterprise Ethically Justifiable?Gianna Gordon, Lisa Kearns
AMA Journal of Ethics|December 18, 2025
Response to "Response to 'Is the UDN N-of-1 Enterprise Ethically Justifiable?'"Gianna Gordon, Lisa Kearns
The American Journal of Bioethics : AJOB|July 25, 2018
"A Little ELF, Please?" The Electronic Long-Form COI Disclosure Statement (ELFCOI)Lisa Kearns, Arthur Caplan
The American Journal of Bioethics : AJOB|March 26, 2024
Collaborations Beyond Conferencing: Exploring Broader Applications of the Anti-Discriminatory, Global, and Inclusive FrameworkTamar Schiff, Lisa Kearns
The American Journal of Bioethics : AJOB|October 12, 2017
Hard Choices for Vulnerable Patients: Some Lessons Learned That May ApplyLisa Kearns, Arthur L Caplan
Nucleic Acid Therapeutics|November 19, 2021
Individualized Therapeutics Development for Rare Diseases: The Current Ethical Landscape and Policy ResponsesAlison Bateman-House, Lisa Kearns
Therapeutic Innovation & Regulatory Science|September 21, 2018
Who Stands to Benefit? Right to Try Law Provisions and ImplicationsLisa Kearns, Alison Bateman-House
Seminars in Neurology|October 16, 2018
Ensuring Justice in Access to Investigational Neurological DrugsLisa Kearns, Alison Bateman-House, Arthur Caplan
Journal of General Internal Medicine|June 17, 2022
Using Telemedicine to Preserve Internal Medicine Residency Continuity Clinic During the COVID-19 Pandemic: Results from a National SurveyLisa Kearns, Denise Dupras, Jordan Ortiz, et al.
The American Journal of Bioethics : AJOB|June 30, 2017
Rethinking the Belmont Report?Phoebe Friesen, Lisa Kearns, Barbara Redman, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
AMA Journal of Ethics|October 1, 2025
Is the UDN N-of-1 Enterprise Ethically Justifiable?Gianna Gordon, Lisa Kearns
AMA Journal of Ethics|December 18, 2025
Response to "Response to 'Is the UDN N-of-1 Enterprise Ethically Justifiable?'"Gianna Gordon, Lisa Kearns
The American Journal of Bioethics : AJOB|July 25, 2018
"A Little ELF, Please?" The Electronic Long-Form COI Disclosure Statement (ELFCOI)Lisa Kearns, Arthur Caplan
The American Journal of Bioethics : AJOB|March 26, 2024
Collaborations Beyond Conferencing: Exploring Broader Applications of the Anti-Discriminatory, Global, and Inclusive FrameworkTamar Schiff, Lisa Kearns
The American Journal of Bioethics : AJOB|October 12, 2017
Hard Choices for Vulnerable Patients: Some Lessons Learned That May ApplyLisa Kearns, Arthur L Caplan
Nucleic Acid Therapeutics|November 19, 2021
Individualized Therapeutics Development for Rare Diseases: The Current Ethical Landscape and Policy ResponsesAlison Bateman-House, Lisa Kearns
Therapeutic Innovation & Regulatory Science|September 21, 2018
Who Stands to Benefit? Right to Try Law Provisions and ImplicationsLisa Kearns, Alison Bateman-House
Seminars in Neurology|October 16, 2018
Ensuring Justice in Access to Investigational Neurological DrugsLisa Kearns, Alison Bateman-House, Arthur Caplan
Journal of General Internal Medicine|June 17, 2022
Using Telemedicine to Preserve Internal Medicine Residency Continuity Clinic During the COVID-19 Pandemic: Results from a National SurveyLisa Kearns, Denise Dupras, Jordan Ortiz, et al.
The American Journal of Bioethics : AJOB|June 30, 2017
Rethinking the Belmont Report?Phoebe Friesen, Lisa Kearns, Barbara Redman, et al.
Pageof 3